Cocrystal Pharma, Inc. (COCP)
USD 1.31
(2.56%)
USD 1.31
(2.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 2.01 Million | 6.56 Million | - |
| Cost of Revenue | 240 Thousand | 241.6 Thousand | 239.5 Thousand | 238.9 Thousand | 4004.00 | 50 Thousand |
| Gross Profit | -15.16 Million | -241.6 Thousand | -239.5 Thousand | 1.77 Million | 6.55 Million | -50 Thousand |
| Operating Expenses | 3.39 Million | 18.13 Million | 14.22 Million | 11.6 Million | 8.86 Million | 62.92 Million |
| Selling, General and Administrative Expenses | 5.99 Million | 5.74 Million | 5.42 Million | 5.29 Million | 4.86 Million | 4.35 Million |
| Research and Development Expenses | 15.16 Million | 12.39 Million | 8.79 Million | 6.3 Million | 4 Million | 58.57 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 18.55 Million | 18.13 Million | 14.22 Million | 11.6 Million | 8.86 Million | 62.92 Million |
| Operating Income | -18.55 Million | -38.82 Million | -14.22 Million | -9.58 Million | -48.4 Million | -62.92 Million |
| Interest Expense | - | 2000.00 | 4000.00 | 8000.00 | 19 Thousand | - |
| Income Tax Expense | - | 8000.00 | 4000.00 | 8000.00 | 19 Thousand | -13.58 Million |
| Earnings before Tax | -17.98 Million | -38.83 Million | -14.18 Million | -9.64 Million | -48.16 Million | -62.63 Million |
| Net Income | -17.98 Million | -38.84 Million | -14.18 Million | -9.65 Million | -48.18 Million | -49.04 Million |
| Earnings Per Share Basic | -1.86 | -4.77 | -0.16 | -0.17 | -1.51 | -21.01 |
| Earnings Per Share Diluted | -1.86 | -4.77 | -0.16 | -0.17 | -1.51 | -21.01 |
| Weighted Average Shares Outstanding | 9.65 Million | 8.14 Million | 88.36 Million | 55.21 Million | 31.85 Million | 2.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 9.65 Million | 8.14 Million | 88.36 Million | 55.21 Million | 31.85 Million | 2.33 Million |
| Gross Margin | - | - | - | 0.88 | 1.00 | - |
| EBIT Margin | - | - | - | -4.68 | -0.34 | - |
| Profit Margin | - | - | - | -4.79 | -7.34 | - |
| EBITDA | -19.37 Million | -38.44 Million | -13.79 Million | -9.3 Million | -47.89 Million | -62.52 Million |
| Earnings Before Tax Margin | - | - | - | -4.76 | -7.37 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 144 Thousand | - | - |
| Cost of Revenue | 33 Thousand | 35 Thousand | -1.38 Million | 72 Thousand | 108 Thousand | 101 Thousand |
| Gross Profit | -33 Thousand | -35 Thousand | 1.38 Million | 72 Thousand | -108 Thousand | -101 Thousand |
| Operating Expenses | 5.41 Million | 4.12 Million | 22.54 Million | 5.66 Million | 6.04 Million | 4.33 Million |
| Selling, General and Administrative Expenses | 1.1 Million | 1.17 Million | - | 1.39 Million | 1.84 Million | 1.53 Million |
| Research and Development Expenses | 4.3 Million | 2.95 Million | - | 4.26 Million | 4.19 Million | 2.8 Million |
| Other Expenses | -4.3 Million | - | - | - | - | - |
| Cost and Expenses | 5.44 Million | 4.15 Million | 21.15 Million | 5.66 Million | 6.04 Million | 4.33 Million |
| Operating Income | -5.44 Million | -4.15 Million | -21.15 Million | -5.66 Million | -4.44 Million | -4.33 Million |
| Interest Expense | - | 220 Thousand | - | -538 Thousand | 320 Thousand | 140 Thousand |
| Income Tax Expense | -1.00 | -1.00 | -1.00 | -30.48 Thousand | -1.87 Million | -173 Thousand |
| Earnings before Tax | -5.34 Million | -3.95 Million | -17.98 Million | -4.46 Million | -4.16 Million | -4.16 Million |
| Net Income | -5.34 Million | -3.95 Million | -17.98 Million | -4.46 Million | -4.16 Million | -4.16 Million |
| Earnings Per Share Basic | -0.53 | -0.39 | - | -0.44 | -0.41 | -0.41 |
| Earnings Per Share Diluted | -0.53 | -0.39 | - | -0.44 | -0.41 | -0.41 |
| Weighted Average Shares Outstanding | 10.17 Million | 10.17 Million | 9.65 Million | 10.17 Million | 10.15 Million | 10.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.17 Million | 10.17 Million | 9.65 Million | 10.17 Million | 10.15 Million | 10.06 Million |
| Gross Margin | - | - | - | 0.50 | - | - |
| EBIT Margin | - | - | - | -51.36 | - | - |
| Profit Margin | - | - | - | -31.00 | - | - |
| EBITDA | -5.41 Million | -4.12 Million | - | -7.39 Million | -7.49 Million | -4.27 Million |
| Earnings Before Tax Margin | - | - | - | -39.35 | - | - |
MTAV
LPPS
5703
001440
688768
2156